medrxiv Subject Collection: Nephrology
http://medrxiv.org
This feed contains articles for medRxiv Subject Collection "Nephrology"
medrxivmedrxivhttps://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png
http://medrxiv.org
<![CDATA[
Prevalence of Enteric Hyperoxaluria in Crohn's Disease, Cystic Fibrosis, and After Bariatric Surgery: A Systematic Review
]]>
https://www.medrxiv.org/content/10.64898/2026.10.07.26364847v1?rss=1
2026-10-09doi:10.64898/2026.10.07.26364847Cold Spring Harbor Laboratory2026-10-09
<![CDATA[
Urinary ER Chaperones - Biomarkers of Glomerular ER Stress
]]>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364164v1?rss=1
40 ml/min/1.73 m2. In MN, there were no significant differences in urinary MANF and ERdj3 between anti-PLA2R positive and negative individuals. In conclusion, proteinuric MN and FSGS show increased glomerular expression of MANF and ERdj3. High urinary levels of these ER chaperones correlate only weakly with proteinuria. In these GNs, urinary ER chaperones are thus non-invasive biomarkers of glomerular/podocyte ER stress. Such biomarkers may eventually be useful in identifying patients for therapies targeting ER protein misfolding.
]]>2026-10-02doi:10.64898/2026.09.28.26364164Cold Spring Harbor Laboratory2026-10-02
<![CDATA[
Spatially resolved transcriptomics of glomerular diseases
]]>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363804v1?rss=1
2026-09-25doi:10.64898/2026.09.23.26363804Cold Spring Harbor Laboratory2026-09-25
<![CDATA[
From Real-World Data to Virtual Intervention: A Probabilistic Neural Network for Simulating Kidney Function Preservation via Proteinuria Reduction
]]>
https://www.medrxiv.org/content/10.64898/2026.07.12.26357786v1?rss=1
2026-07-17doi:10.64898/2026.07.12.26357786Cold Spring Harbor Laboratory2026-07-17
<![CDATA[
Multi-Agent Dynamic Refinement Outperforms Static RAG in Clinical Reasoning for Complex Nephrology Cases
]]>
https://www.medrxiv.org/content/10.64898/2026.07.15.26358121v1?rss=1
2026-07-20doi:10.64898/2026.07.15.26358121Cold Spring Harbor Laboratory2026-07-20
<![CDATA[
Switching from febuxostat to dotinurad in patients with chronic kidney disease and hyperuricemia: a single-center, non-randomized study
]]>
https://www.medrxiv.org/content/10.64898/2026.07.16.26358294v1?rss=1
2026-07-21doi:10.64898/2026.07.16.26358294Cold Spring Harbor Laboratory2026-07-21
<![CDATA[
Microvascular Thrombosis and Acute Kidney Injury in COVID-19: A Systematic Review and Quantitative Analysis
]]>
https://www.medrxiv.org/content/10.64898/2026.07.14.26357748v1?rss=1
2026-07-21doi:10.64898/2026.07.14.26357748Cold Spring Harbor Laboratory2026-07-21
<![CDATA[
Resolving the classification rates and molecular architecture of early-onset chronic kidney disease with NephVar
]]>
https://www.medrxiv.org/content/10.64898/2026.07.22.26358680v1?rss=1
2026-07-27doi:10.64898/2026.07.22.26358680Cold Spring Harbor Laboratory2026-07-27
<![CDATA[
Uromodulin T62P variant causes kidney tubular stress and injury modulated by age and polygenic risk
]]>
https://www.medrxiv.org/content/10.64898/2026.07.29.26359269v1?rss=1
2026-08-03doi:10.64898/2026.07.29.26359269Cold Spring Harbor Laboratory2026-08-03
<![CDATA[
Non-invasive {superscript 2}3Na MRI Identifies Functionally Distinct Cyst Phenotypes in Autosomal Dominant Polycystic Kidney Disease
]]>
https://www.medrxiv.org/content/10.64898/2026.07.30.26359242v1?rss=1
2026-08-04doi:10.64898/2026.07.30.26359242Cold Spring Harbor Laboratory2026-08-04
<![CDATA[
Natural History and Post-transplant Outcomes Among Patients with Kidney Leukocyte Cell-Derived
]]>
https://www.medrxiv.org/content/10.64898/2026.07.31.26359278v1?rss=1
2026-08-05doi:10.64898/2026.07.31.26359278Cold Spring Harbor Laboratory2026-08-05
<![CDATA[
Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Medication Titration Practices in Hemodialysis Patients in the US
]]>
https://www.medrxiv.org/content/10.64898/2026.08.02.26359426v1?rss=1
2026-08-06doi:10.64898/2026.08.02.26359426Cold Spring Harbor Laboratory2026-08-06
<![CDATA[
Change of prognostic nutritional index after three months of initial hemodialysis is a predictor of long-term outcomes for patients with uremia
]]>
https://www.medrxiv.org/content/10.64898/2026.08.05.26359770v1?rss=1
60 years old; p=0.022) patient groups. Both the PNI and GNRI showed a downward trend before death, but only PNI had a significant decline (p=0.03, compared with PNI after three months of MHD). In conclusion, for patients undergoing MHD, the correlation between PNI and prognosis is closer than that of GNRI, and the PNI after three months of MHD is a statistically significant but moderate predictor of long-term outcomes.
]]>2026-08-10doi:10.64898/2026.08.05.26359770Cold Spring Harbor Laboratory2026-08-10
<![CDATA[
The Urine Ammonium-pH Index is a Measure of Kidney Tubular Function
]]>
https://www.medrxiv.org/content/10.64898/2026.08.06.26359870v1?rss=1
2026-08-11doi:10.64898/2026.08.06.26359870Cold Spring Harbor Laboratory2026-08-11
<![CDATA[
Genetic and environmental risk factors for intracranial aneurysm and subarachnoid haemorrhage among patients with Autosomal Dominant Polycystic Kidney Disease
]]>
https://www.medrxiv.org/content/10.64898/2026.08.07.26359892v1?rss=1
2026-08-12doi:10.64898/2026.08.07.26359892Cold Spring Harbor Laboratory2026-08-12
<![CDATA[
The Dietary Approaches to Stop Hypertension (DASH) diet score and its association with the Risk of Kidney Function Decline and Mortality among Veterans in the Million Veteran Program
]]>
https://www.medrxiv.org/content/10.64898/2026.08.11.26360178v1?rss=1
2026-08-14doi:10.64898/2026.08.11.26360178Cold Spring Harbor Laboratory2026-08-14
<![CDATA[
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World Data
]]>
https://www.medrxiv.org/content/10.64898/2026.08.11.26360158v1?rss=1
2026-08-14doi:10.64898/2026.08.11.26360158Cold Spring Harbor Laboratory2026-08-14
<![CDATA[
Robustness Gap of Large Language Models in Nephrology
]]>
https://www.medrxiv.org/content/10.64898/2026.08.17.26360565v1?rss=1
2026-08-20doi:10.64898/2026.08.17.26360565Cold Spring Harbor Laboratory2026-08-20
<![CDATA[
Heterozygous truncating variants in BICC1 are a novel cause of autosomal-dominant tubulointerstitial kidney disease
]]>
https://www.medrxiv.org/content/10.64898/2026.08.20.26360556v1?rss=1
2026-08-26doi:10.64898/2026.08.20.26360556Cold Spring Harbor Laboratory2026-08-26
<![CDATA[
IgA1 hinge-region O-glycoform signatures associated with disease phase and kidney involvement in pediatric IgA vasculitis: a cross-sectional mass-spectrometry study
]]>
https://www.medrxiv.org/content/10.64898/2026.08.21.26361008v1?rss=1
2026-08-26doi:10.64898/2026.08.21.26361008Cold Spring Harbor Laboratory2026-08-26
<![CDATA[
Renal Outcomes in Survivors of Neonatal and Pediatric Renal Vein Thrombosis
]]>
https://www.medrxiv.org/content/10.64898/2026.08.25.26361338v1?rss=1
2026-08-31doi:10.64898/2026.08.25.26361338Cold Spring Harbor Laboratory2026-08-31
<![CDATA[
Belimumab with rituximab for the treatment of primary membranous nephropathy
]]>
https://www.medrxiv.org/content/10.64898/2026.08.26.26360913v1?rss=1
8 g/day) proteinuria at week 4. Among all treated participants, 59% (10/17) achieved CR/PR at week 104, while in per protocol analyses, 91% (10/11) achieved CR/PR at week 104. All participants in per protocol analyses had normal serum albumin and undetectable serum anti-PLA2R by week 104. Circulating memory B cells increased before rituximab and were depleted by rituximab. B cell re-constitution occurred after week 52 with primarily naive and transitional B cells. Belimumab with rituximab was well-tolerated, with one participant discontinuing belimumab due to infection.
ConclusionIn this study, a high proportion of participants receiving belimumab with rituximab achieved CR/PR. Thus, a multi-targeted approach to B cell depletion may improve immunologic and clinical outcomes in PMN and is being studied in a larger, randomized, placebo-controlled clinical trial.
]]>2026-09-02doi:10.64898/2026.08.26.26360913Cold Spring Harbor Laboratory2026-09-02
<![CDATA[
Urinary collagen type I degradation products as common fibrosis biomarkers in chronic diseases
]]>
https://www.medrxiv.org/content/10.64898/2026.08.26.26361420v1?rss=1
2026-09-02doi:10.64898/2026.08.26.26361420Cold Spring Harbor Laboratory2026-09-02
<![CDATA[
Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults
]]>
https://www.medrxiv.org/content/10.64898/2026.09.15.26363188v1?rss=1
2026-09-18doi:10.64898/2026.09.15.26363188Cold Spring Harbor Laboratory2026-09-18
<![CDATA[
Association between blood urea nitrogen-to-albumin ratio and kidney stones: A cross-sectional study based on NHANES
]]>
https://www.medrxiv.org/content/10.64898/2026.09.16.26363211v1?rss=1
1, P < 0.05). Subgroup analyses revealed stable associations in females (OR = 1.10, P < 0.001), low vitamin A intake (OR = 1.10, P < 0.001), high water intake (OR = 1.11, P < 0.001), age < 50 years (OR = 1.14, P < 0.01), and education less than high school (OR = 1.11, P < 0.01). XGBoost identified BAR and water intake as prominent risk factors (AUC = 0.658). External validation confirmed a positive association (Model 1 OR = 1.029, 95% CI 1.016-1.043; Model 2 OR = 1.030, 95% CI 1.016-1.044; Model 3 OR = 1.029, 95% CI 1.015-1.045; all P < 0.001), and RCS confirmed a nonlinear dose-response relationship (nonlinear P = 0.0006). Subgroups aged [≥] 60 years, males, and females showed significant associations (ORs = 1.027-1.034). In XGBoost, BAR was the most important predictor (Gain = 0.265). These findings reveal a significant association between BAR and kidney stones, offering theoretical insights for prevention and risk stratification; BAR may serve as a valuable marker in kidney stone management.
]]>2026-09-18doi:10.64898/2026.09.16.26363211Cold Spring Harbor Laboratory2026-09-18
<![CDATA[
Characterization of the neoprotein MUC1-fs in patient-derived cells with ADTKD-MUC1
]]>
https://www.medrxiv.org/content/10.64898/2026.09.16.26363125v1?rss=1
2026-09-16doi:10.64898/2026.09.16.26363125Cold Spring Harbor Laboratory2026-09-16
<![CDATA[
The APOL1 protective M1 modifier occurs exclusively with the KIK protein haplotype to suppress channel conductance
]]>
https://www.medrxiv.org/content/10.64898/2026.09.14.26362999v1?rss=1
2026-09-15doi:10.64898/2026.09.14.26362999Cold Spring Harbor Laboratory2026-09-15
<![CDATA[
Interpretable biomarker programs predict treatment response in lupus nephritis: patient-level validation across four regimens
]]>
https://www.medrxiv.org/content/10.64898/2026.09.13.26362948v1?rss=1
2026-09-15doi:10.64898/2026.09.13.26362948Cold Spring Harbor Laboratory2026-09-15
<![CDATA[
Red blood cell distribution width is an indicator of physiological dysregulation and reveals the relationship between biomarkers and health status in hemodialysis patients
]]>
https://www.medrxiv.org/content/10.64898/2026.09.04.26362306v1?rss=1
2026-09-08doi:10.64898/2026.09.04.26362306Cold Spring Harbor Laboratory2026-09-08
<![CDATA[
Cross-System Meta-Analysis of Machine Learning Predictors Identifies Value-Specific Risk Drivers and Interactions Underlying Acute Kidney Injury
]]>
https://www.medrxiv.org/content/10.64898/2026.08.31.26361849v1?rss=1
2026-09-02doi:10.64898/2026.08.31.26361849Cold Spring Harbor Laboratory2026-09-02